ASO Visual Abstract: Development and Validation of a Recurrence-Free Survival Prediction Model for Locally Advanced Esophageal Squamous Cell Carcinoma with Neoadjuvant Chemoradiotherapy
机构：[1]Department of Pathology, Sichuan Cancer Hospital and Institute, Sichuan Cancer Center, School of Medicine, University of Electronic Science and Technology of China, Chengdu, China.四川省人民医院四川省肿瘤医院[2]Department of Thoracic Surgery, Sichuan Cancer Hospital and Institute, Sichuan Cancer Center, School of Medicine, University of Electronic Science and Technology of China, Chengdu, China.外科中心胸外科中心四川省人民医院四川省肿瘤医院
第一作者机构：[1]Department of Pathology, Sichuan Cancer Hospital and Institute, Sichuan Cancer Center, School of Medicine, University of Electronic Science and Technology of China, Chengdu, China.
共同第一作者：
通讯作者：
推荐引用方式(GB/T 7714)：
Zhou Yehan,He Wenwu,Huang Zongyao,et al.ASO Visual Abstract: Development and Validation of a Recurrence-Free Survival Prediction Model for Locally Advanced Esophageal Squamous Cell Carcinoma with Neoadjuvant Chemoradiotherapy[J].Annals Of Surgical Oncology.2023,doi:10.1245/s10434-023-14736-1.
APA：
Zhou Yehan,He Wenwu,Huang Zongyao&Liu Yang.(2023).ASO Visual Abstract: Development and Validation of a Recurrence-Free Survival Prediction Model for Locally Advanced Esophageal Squamous Cell Carcinoma with Neoadjuvant Chemoradiotherapy.Annals Of Surgical Oncology,,
MLA：
Zhou Yehan,et al."ASO Visual Abstract: Development and Validation of a Recurrence-Free Survival Prediction Model for Locally Advanced Esophageal Squamous Cell Carcinoma with Neoadjuvant Chemoradiotherapy".Annals Of Surgical Oncology .(2023)
医学